arginine has been researched along with pyridoxamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audic, N; Ermolenko, L; Franck, G; Garcia-Alvarez, MC; Martin, MT; Nhiri, N; Potier, P; Sasaki, NA; Wang, Q | 1 |
| Snell, EE | 1 |
| Brooks, HB; Osterman, AL; Phillips, MA; Rizo, J | 1 |
| di Salvo, ML; Ko, TP; Musayev, FN; Raboni, S; Safo, MK; Schirch, V | 1 |
| Biemel, KM; Lederer, MO; Mally, A; Nagaraj, RH; Padayatti, PS; Sarkar, P | 1 |
| Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN | 1 |
| Culbertson, SM; Ingold, KU; Morrison, LD; Vassilenko, EI | 1 |
| Inagi, R; Izuhara, Y; Kakuta, T; Miyata, T; Nangaku, M; Saito, A; Satoh, Y; Tanaka, R | 1 |
| Chetyrkin, SV; Chuang, P; Ham, AJ; Hudson, BG; Mathieson, PW; Pedchenko, VK; Saleem, MA; Voziyan, PA | 1 |
| Nagaraj, RH; Padival, S | 1 |
| Barter, PJ; Brown, BE; Davies, MJ; Nobécourt, E; Rye, KA; Yadav, S; Zeng, J | 1 |
| Bidasee, KR; Kutty, S; Moore, CJ; Nagai, R; Shao, CH; Singh, J | 1 |
| Arai, M; Horiuchi, Y; Itokawa, M; Kobori, A; Miyashita, M; Toriumi, K | 1 |
| Amano, N; Arai, M; Dan, T; Horiuchi, Y; Ichikawa, T; Ishimoto, K; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Okazaki, Y; Takahashi, K; Tokunaga, T; Toriumi, K; Usami, S; Washizuka, S; Yoshikawa, T | 1 |
2 review(s) available for arginine and pyridoxamine
| Article | Year |
|---|---|
Analogs of pyridoxal or pyridoxal phosphate: relation of structure to binding with apoenzymes and to catalytic activity.
Topics: Apoproteins; Arginine; Aspartic Acid; Carboxy-Lyases; Catalysis; Chemical Phenomena; Chemistry; Coenzymes; Hydrolases; L-Serine Dehydratase; Models, Biological; Organophosphorus Compounds; Phosphorylases; Picolines; Protein Binding; Protein Conformation; Pyridines; Pyridoxal; Pyridoxal Phosphate; Pyridoxamine; Pyridoxine; Pyruvates; Structure-Activity Relationship; Transaminases; Tryptophan | 1970 |
Carbonyl stress and schizophrenia.
Topics: Arginine; Biomarkers; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Mutation; Psychiatric Status Rating Scales; Pyridoxal; Pyridoxamine; Schizophrenia; Stress, Physiological | 2014 |
12 other study(ies) available for arginine and pyridoxamine
| Article | Year |
|---|---|
N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation.
Topics: beta-Alanine; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Glycation End Products, Advanced; Magnetic Resonance Spectroscopy; Peptides; Pyruvaldehyde | 2009 |
Role of Arg-277 in the binding of pyridoxal 5'-phosphate to Trypanosoma brucei ornithine decarboxylase.
Topics: Animals; Arginine; Binding Sites; Circular Dichroism; Kinetics; Magnetic Resonance Spectroscopy; Mutagenesis, Site-Directed; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Pyridoxal Phosphate; Pyridoxamine; Spectrophotometry, Ultraviolet; Trypanosoma brucei brucei; Ultrafiltration | 1997 |
Active site structure and stereospecificity of Escherichia coli pyridoxine-5'-phosphate oxidase.
Topics: Arginine; Binding Sites; Crystallization; Crystallography, X-Ray; Electron Transport; Escherichia coli; Flavin Mononucleotide; Hydrogen; Hydrogen Bonding; Kinetics; Models, Molecular; Mutation; Protein Structure, Secondary; Pyridoxal Phosphate; Pyridoxamine; Pyridoxaminephosphate Oxidase; Stereoisomerism; Substrate Specificity; Tyrosine; Water | 2002 |
Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
Topics: Animals; Arginine; Cattle; Chromatography, High Pressure Liquid; Crystallins; Diabetes Mellitus, Experimental; Dimerization; Erythrocytes; Glutathione; Glycation End Products, Advanced; Lactoylglutathione Lyase; Lysine; Magnetic Resonance Spectroscopy; Maillard Reaction; Models, Chemical; Oxidative Stress; Pyridoxamine; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances | 2002 |
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, Advanced; Hyperlipidemias; Hypertension; Kidney; Kidney Diseases; Lysine; Pyridoxamine; Rats; Rats, Zucker; Skin; Weight Gain | 2003 |
Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.
Topics: Antioxidants; Arginine; Biochemistry; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Glucose; Glycation End Products, Advanced; Ions; Lysine; Models, Chemical; Pyridoxamine; Ribose; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2003 |
Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats.
Topics: Animals; Arginine; Creatinine; Fibroblast Growth Factor 2; Glucose; Glycation End Products, Advanced; Lysine; Male; Nephrectomy; Peritoneal Dialysis; Peritoneum; Peritonitis; Pyridoxamine; Rats; Rats, Sprague-Dawley; Uremia; Vascular Endothelial Growth Factor A; Vitamin B Complex | 2005 |
Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.
Topics: Aldehydes; Arginine; Binding Sites; Cell Adhesion; Cell Physiological Phenomena; Collagen Type IV; Diabetic Nephropathies; Endothelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Glucose; Glyoxal; Humans; Integrin alphaVbeta3; Integrins; Kidney; Kidney Glomerulus; Pyridoxamine; Pyruvaldehyde; Umbilical Veins | 2005 |
Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
Topics: Aldehyde Reductase; Animals; Arginine; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Experimental; Glucose; Glutathione; Glycation End Products, Advanced; Lactoylglutathione Lyase; Lens Diseases; Lens, Crystalline; Lysine; Maillard Reaction; Male; Organ Culture Techniques; Ornithine; Pyridoxamine; Pyrimidines; Pyruvaldehyde; Rats; Rats, Sprague-Dawley | 2006 |
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
Topics: Apolipoprotein A-I; Arginine; Cross-Linking Reagents; Glycosylation; Guanidines; Humans; Lipoproteins, HDL; Lysine; Metformin; Phosphatidylcholine-Sterol O-Acyltransferase; Pyridoxamine; Pyruvaldehyde; Thiazoles; Tryptophan | 2008 |
Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
Topics: Aldehydes; Animals; Arginine; Calcium; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Guanidines; Lysine; Male; Malondialdehyde; Myocytes, Cardiac; Norleucine; Protein Carbonylation; Pyridoxamine; Pyrroles; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spin Labels | 2013 |
Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Drug Therapy, Combination; Female; Humans; Lactoylglutathione Lyase; Lysine; Male; Middle Aged; Outcome Assessment, Health Care; Oxidative Stress; Pyridoxamine; Schizophrenia; Vitamin B Complex | 2018 |